NCT07924436 Whole-Body Vibration Training in Women With Obesity With and Without Type 2 Diabetes
| NCT ID | NCT07924436 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Pamukkale University |
| Condition | Obesity |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-11-09 |
| Primary Completion | 2027-01-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-11-09 with a primary completion date of 2027-01-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will examine changes in ankle muscle activity and functional performance following whole-body vibration training in women with obesity, with and without type 2 diabetes. It will also compare the responses to training between these two groups. Participants will attend supervised training twice a week for eight weeks. During training, they will perform exercises on a platform that produces mechanical vibrations. The exercises will progress gradually and will be adapted to each participant's abilities and tolerance. Each session will include warm-up and cool-down exercises. Before and after the training program, researchers will assess muscle activity during normal walking, heel-to-toe walking, and standing with one foot directly in front of the other. Small sensors placed on the skin will record activity from three muscles around each ankle. Walking and functional performance will also be assessed. The study aims to help researchers understand whether women with obesity with and without type 2 diabetes show different changes in muscle activity and functional performance after the same training program.
Eligibility Criteria
Inclusion Criteria: * Female. * Aged 18 to 65 years. * Body mass index (BMI) ≥30 kg/m². * Willing to participate and provide informed consent. * For Group 1: Presence of type 2 diabetes mellitus. * For Group 2: Absence of type 2 diabetes mellitus. Exclusion Criteria: * Cardiopulmonary, orthopedic, or neurological conditions that prevent participation in physical activity. * Congenital musculoskeletal deformities. * Cognitive impairment that prevents effective communication. * Presence of osteoporosis or osteopenia.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07924436 clinical trial?
This trial is open to female participants only, aged 18 Years or older, up to 65 Years, studying Obesity. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07924436 currently recruiting?
Yes, NCT07924436 is actively recruiting participants. Contact the research team at umbaslan@pau.edu.tr for enrollment information.
Where is the NCT07924436 trial being conducted?
This trial is being conducted at Denizli, Turkey (Türkiye).
Who is sponsoring the NCT07924436 clinical trial?
NCT07924436 is sponsored by Pamukkale University. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.